UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Solid-phase/supercritical-fluid extraction for liquid chromatography of phenolic compounds in freshwater microalgae and selected cyanobacterial species

Journal of Chromatography A, 2009-01, Vol.1216 (5), p.763-771

2009

Volltextzugriff (PDF)

Ultrahigh-pressure liquid chromatography of isoflavones and phenolic acids on different stationary phases

Journal of Chromatography A, 2008-06, Vol.1195 (1), p.52-59

2008

Volltextzugriff (PDF)

Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients

Analytical biochemistry, 2013-02, Vol.433 (2), p.227-234

2013

Volltextzugriff (PDF)

Rapid-resolution HPLC with spectrometric detection for the determination and identification of isoflavones in soy preparations and plant extracts

Analytical and bioanalytical chemistry, 2007-12, Vol.389 (7-8), p.2277-2285

2007

Volltextzugriff (PDF)

A comparison of biodegradable municipal waste (BMW) management strategies in Ireland and the Czech Republic and the lessons learned

Resources, conservation and recycling, 2014-11, Vol.92, p.136-144

2014

Volltextzugriff (PDF)

IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas

Folia biologica, 2016-01, Vol.62 (5), p.194-202

2016

Volltextzugriff (PDF)

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

Neoplasma, 2016, Vol.63 (3), p.471-476

2016

Volltextzugriff (PDF)

Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer

World journal of gastroenterology : WJG, 2007-07, Vol.13 (27), p.3714

2007

Volltextzugriff (PDF)

Impact of urban drainage on metal distribution in sediments of urban streams

Water science and technology, 2009-01, Vol.59 (6), p.1237-1246

2009

Volltextzugriff (PDF)

Current possibilities of predicting the therapeutic response to neoadjuvant chemoradiotherapy in rectal cancer

Gastroenterologie a hepatologie, 2020-10, Vol.74 (5), p.393-403

2020

Volltextzugriff (PDF)

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy

Folia biologica, 2014, Vol.60 (1), p.28-34

2014

Volltextzugriff (PDF)

Circulating tumor DNA as a biomarker in metastatic colorectal carcinoma − case report

Rozhledy v chirurgii, 2020-04, Vol.99 (4), p.179-182

2020

Volltextzugriff (PDF)

149 Quantitative mutational assessment of circulating tumor DNA using massively parallel deep sequencing in plasma and urine from advanced colorectal cancer patients

European journal of cancer (1990), 2014-11, Vol.50, p.51-51

2014

Volltextzugriff (PDF)

73P GENE MUTATIONS IN SQUAMOUS-CELL NSCLC: INSIGNIFICANCE OF EGFR, KRAS AND PIK3CA MUTATIONS IN PREDICTION OF EGFR-TKI TREATMENT EFFICACY

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S33-S33

2013

Volltextzugriff (PDF)

Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice

Neoplasma, 2013-01, Vol.60 (1), p.26-32

2013

Volltextzugriff (PDF)

9093 POSTER The Role of Specific KRAS Mutation Types in Response to Treatment by EGFR Inhibitors

European journal of cancer (1990), 2011, Vol.47, p.S620-S620

2011

Volltextzugriff (PDF)

Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC

Neoplasma, 2013, Vol.60 (4), p.425-431

2013

Volltextzugriff (PDF)

9074 POSTER DNA Hypermethylation in Progressive Advanced Non Small Cell Lung Cancer

European journal of cancer (1990), 2011, Vol.47, p.S614-S614

2011

Volltextzugriff (PDF)

Erlotinib in the treatment of advanced squamous cell NSCLC

Neoplasma, 2013-01, Vol.60 (6), p.676-682

2013

Volltextzugriff (PDF)

Acquired Resistance of Pulmonary Adenocarcinoma to Initially Successful Targeted Therapy due to EGFR Mutation T790M

Anticancer research, 2007-07, Vol.27 (4A), p.1879-1882

2007

Volltextzugriff (PDF)

EGFR mutations in patients with advanced NSCLC

Klinická onkologie, 2012, Vol.25 (4), p.267-273

2012

Volltextzugriff (PDF)

Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification

Cancer genomics & proteomics, 2011-05, Vol.8 (3), p.135-138

2011

Volltextzugriff (PDF)

Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacy

Anticancer research, 2013-04, Vol.33 (4), p.1705-1711

2013

Volltextzugriff (PDF)

Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors

Anticancer research, 2010-05, Vol.30 (5), p.1667-1671

2010

Volltextzugriff (PDF)

P817 Profiles of somatic mutations in tissue of IBD and IBD-associated carcinomas revealed by a targeted next-generation sequencing (NGS) tumour panel confirm notable differences from sporadic colorectal carcinomas

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S531-S531

2019

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Solid-phase/supercritical-fluid extraction for liquid chromatography of phenolic compounds in freshwater microalgae and selected cyanobacterial species

Ultrahigh-pressure liquid chromatography of isoflavones and phenolic acids on different stationary phases

Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients

Rapid-resolution HPLC with spectrometric detection for the determination and identification of isoflavones in soy preparations and plant extracts

A comparison of biodegradable municipal waste (BMW) management strategies in Ireland and the Czech Republic and the lessons learned

IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer

Impact of urban drainage on metal distribution in sediments of urban streams

Current possibilities of predicting the therapeutic response to neoadjuvant chemoradiotherapy in rectal cancer

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy

Circulating tumor DNA as a biomarker in metastatic colorectal carcinoma − case report

149 Quantitative mutational assessment of circulating tumor DNA using massively parallel deep sequencing in plasma and urine from advanced colorectal cancer patients

73P GENE MUTATIONS IN SQUAMOUS-CELL NSCLC: INSIGNIFICANCE OF EGFR, KRAS AND PIK3CA MUTATIONS IN PREDICTION OF EGFR-TKI TREATMENT EFFICACY

Skin rash as useful marker of erlotinib efficacy in NSCLC and its impact on clinical practice

9093 POSTER The Role of Specific KRAS Mutation Types in Response to Treatment by EGFR Inhibitors

Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC

9074 POSTER DNA Hypermethylation in Progressive Advanced Non Small Cell Lung Cancer

Erlotinib in the treatment of advanced squamous cell NSCLC

Acquired Resistance of Pulmonary Adenocarcinoma to Initially Successful Targeted Therapy due to EGFR Mutation T790M

EGFR mutations in patients with advanced NSCLC

Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification

Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacy

Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors

P817 Profiles of somatic mutations in tissue of IBD and IBD-associated carcinomas revealed by a targeted next-generation sequencing (NGS) tumour panel confirm notable differences from sporadic colorectal carcinomas

Suchergebnisse filtern